Mouse clinical trials of pancreatic cancer: Integration of PDX models with genomics to improve patient outcomes to chemotherapeutics

被引：2
|
作者：
Davies, A. [1 ]
Hidalgo, M. [2 ]
Stebbing, J. [3 ]
Ciznadija, D. [4 ]
Katz, A. [4 ]
Sidransky, D. [5 ]
机构：
[1] Champ Oncol, Med Affairs, Hackensack, NJ USA
[2] Hosp Madrid Norte San Chinarro, Ctr Integral Oncol Clara Campal, CIOCC, Madrid, Spain
[3] Imperial Coll London, Hammersmith Hosp, Surg & Canc, London, England
[4] Champ Oncol, Translat Oncol, Hackensack, NJ USA
[5] Johns Hopkins Univ Hosp, Med, Baltimore, MD 21287 USA
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
10.1093/annonc/mdw392.4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1522P
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Targeting Epigenetic Aberrations in Pancreatic Cancer, a New Path to Improve Patient Outcomes?
    Paradise, Brooke D.
    Barham, Whitney
    Fernandez-Zapico, Martin E.
    CANCERS, 2018, 10 (05)
  • [22] Harnessing preclinical mouse models to inform human clinical cancer trials
    Gutmann, DH
    Hunter-Schaedle, K
    Shannon, KM
    JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (04): : 847 - 852
  • [23] The mouse tumor biology database (MTB): An integrated data resource for mouse and patient derived xenograft (PDX) models of human cancer
    Begley, Dale A.
    Krupke, Debbie M.
    Neuhauser, Steven B.
    Richardson, Joel E.
    Sundberg, John P.
    Eppig, Janan T.
    Bult, Carol J.
    CANCER RESEARCH, 2016, 76
  • [24] The prognostic significance of patient-reported outcomes in cancer clinical trials
    Gotay, Carolyn C.
    Kawamoto, Crissy T.
    Bottomley, Andrew
    Efficace, Fabio
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (08) : 1355 - 1363
  • [25] Trustworthiness of Patient-Reported Outcomes in Unblinded Cancer Clinical Trials
    Atkinson, Thomas M.
    Wagner, Jan-Samuel
    Basch, Ethan
    JAMA ONCOLOGY, 2017, 3 (06) : 738 - 739
  • [26] Reflections on estimands for patient-reported outcomes in cancer clinical trials
    Lawrance, Rachael
    Skaltsa, Konstantina
    Regnault, Antoine
    Floden, Lysbeth
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2023,
  • [27] The importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical trials
    Anker, Stefan D.
    Agewall, Stefan
    Borggrefe, Martin
    Calvert, Melanie
    Caro, J. Jaime
    Cowie, Martin R.
    Ford, Ian
    Paty, Jean A.
    Riley, Jillian P.
    Swedberg, Karl
    Tavazzi, Luigi
    Wiklund, Ingela
    Kirchhof, Paulus
    EUROPEAN HEART JOURNAL, 2014, 35 (30) : 2001 - +
  • [28] PATIENT-REPORTED OUTCOMES (PROS) IN OVARIAN CANCER CLINICAL TRIALS
    Pease, S.
    Barsdorf, A., I
    VALUE IN HEALTH, 2015, 18 (03) : A210 - A210
  • [29] Patient education intervention to improve breast cancer clinical trials participation.
    Shafaee, Maryam Nemati
    Simmons, Kristen
    Podany, Emily L.
    Hernandez-Herrera, Anadulce
    Hoyos, Valentina
    Henry, Giselle
    Sanchez, Daisy
    Coronel, Cristina
    Hildebrandt, Rebecca
    Bulsara, Shaun
    Hilsenbeck, Susan G.
    Niravath, Polly Ann
    Badr, Hoda
    Ellis, Matthew James
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18532 - E18532
  • [30] Restructuring English oncology: Will it improve participation in clinical trials and cancer patient care?
    不详
    ANNALS OF ONCOLOGY, 2001, 12 (02) : 139 - 139
12345